Literature DB >> 713424

Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis.

T R Weihrauch, G W Korting, K Ewe, G Vogt.   

Abstract

In 25 patients with progressive systemic sclerosis esophageal involvement was studied prospectively by analysing subjective symptoms and radiological and manometric criteria. In all patients abnormal motility could be demonstrated by X-ray and/or manometry: radiologically in 18 (72%), manometrically in 22 (88%) cases. Dysphagia was present only in 11 patients (44%). Six patients (24%) had no subjective symptoms in spite of severe objective esophageal abnormalities. Therefore, the absence of esophageal symptoms does not exclude advanced affliction of the esophagus. To determine the pathogenesis of esophageal dysfunction the effects of 3.5 microgram/kg carbachol and of 0.6 microgram/kg pentagastrin i.m. on the lower esophageal sphincter pressure (LESP), on the amplitude and on the duration of peristaltic esophageal contractions were studied at random in 12 of the patients and 12 normal controls. The results suggest a primary myogenic genesis of the motor abnormalities by atrophy and sclerosis of esophageal smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 713424     DOI: 10.1007/bf01480150

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  19 in total

1.  SCLERODERMA OF THE ESOPHAGUS. A CORRELATION OF HISTOLOGIC AND PHYSIOLOGIC FINDINGS.

Authors:  W L TREACY; A H BAGGENSTOSS; C H SLOCUMB; C F CODE
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

2.  Esophageal motility in patients with scleroderma and related diseases.

Authors:  B CREAMER; H A ANDERSEN; C F CODE
Journal:  Gastroenterologia       Date:  1956

3.  [Various dermatologic prolegomena concerning the current collagen research].

Authors:  G W Korting
Journal:  Hautarzt       Date:  1976-05       Impact factor: 0.751

4.  [Surgical evidence for the neural origin of scleroderma].

Authors:  J L Lortat-Jacob; R Giuli; B Estenne; B Duperrat; J Conte-Marti
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1974

5.  Esophageal dysfunction in collagen disease.

Authors:  R Turner; W Lipshutz; W Miller; G Rittenberg; H R Schumacher; S Cohen
Journal:  Am J Med Sci       Date:  1973-03       Impact factor: 2.378

Review 6.  [Lines of development in present scleroderma research].

Authors:  G W Korting; H Holzmann
Journal:  Ergeb Inn Med Kinderheilkd       Date:  1966

7.  Esophageal deterioration in scleroderma.

Authors:  J M Garrett; R K Winkelmann; J F Schlegel; C F Code
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

8.  Esophageal motility in systemic lupus erythematosus, rheumatoid arthritis, and scleroderma.

Authors:  M Tatelman; M K Keech
Journal:  Radiology       Date:  1966-06       Impact factor: 11.105

9.  Oesophageal changes in systemic sclerosis.

Authors:  M Atkinson; M D Summerling
Journal:  Gut       Date:  1966-08       Impact factor: 23.059

10.  [Manometric study of esophageal involvement in progressive systemic sclerosis (author's transl)].

Authors:  T R Weihrauch; K Ewe; H Weis; G W Korting
Journal:  Arch Dermatol Res       Date:  1975-11-14       Impact factor: 3.017

View more
  7 in total

1.  Long-term manometry of tubular esophagus in progressive systemic sclerosis.

Authors:  R J Adamek; M Wegener; M Wienbeck; H Köhler; K Hoffmann; P Altmeyer
Journal:  Clin Investig       Date:  1994-05

2.  Barrett's esophagus complicating scleroderma.

Authors:  F P Agha; L Dabich
Journal:  Gastrointest Radiol       Date:  1985

Review 3.  Scleroderma esophagus.

Authors:  S R Fulp; D O Castell
Journal:  Dysphagia       Date:  1990       Impact factor: 3.438

4.  Early endoscopy in systemic sclerosis without gastrointestinal symptoms.

Authors:  Rene Thonhofer; Cornelia Siegel; Markus Trummer; Winfried Graninger
Journal:  Rheumatol Int       Date:  2010-08-14       Impact factor: 2.631

5.  Manometric evaluation of esophageal function in progressive systemic sclerosis with special regard to the disease severity.

Authors:  Y Koshino; T Takai; T Kato; H Moriwaki; Y Muto; Y Shikano; M Maeda; S Mori
Journal:  Gastroenterol Jpn       Date:  1991-10

6.  Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity?

Authors:  E B Tsianos; A A Drosos; C D Chiras; H M Moutsopoulos; R C Kitridou
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

Review 7.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.